DENVER - Inviragen of Fort Collins is among 17 regional companies chosen to showcase their technologies at the Rocky Mountain Life Science Investor Conference on Thursday, Sept. 17 at the Ritz Carlton in Denver.

The companies selected during this first round also include six firms from the Boulder area, as well as from Aurora, Salt Lake City and three cities in Arizona. A total of 30 regional companies will be given the opportunity to present to a targeted audience of national investors at the inaugural event co-hosted by the Colorado Bioscience Association and the Arizona BioIndustry Organization along with industry partners in Montana, Utah and New Mexico.

"The Rocky Mountain Life Science Investor Conference is the region's first and only life science investor conference and will bring together leading investors, emerging companies and senior executives to cultivate partnerships within the industry," said CBSA President and CEO John Collar in announcing the first-round picks. "The conference will be an impressive representation of the region's efforts in the life science arena."

To learn more about the conference, visit www.rmlic.com.